Most Read Articles
Stephen Padilla, 4 days ago
Diabetic patients in a decompensated state and who develop type 2 myocardial infarction (MI) have an increased risk for mortality and major adverse cardiac events (MACE), according to a new study. In addition, these patients are potentially at risk for undiagnosed coronary artery disease.
6 days ago
Chocolate consumption is not associated with risk of coronary heart disease (CHD), stroke or both combined in postmenopausal women free of pre-existing major chronic disease, a study suggests.
Pearl Toh, 13 Jul 2018
More intensive lowering of LDL-C levels was associated with a progressively greater survival benefit than less intensive approach, when the baseline LDL-C levels were ≥100 mg/dL, reveals a meta-analysis of 34 randomized trials.
6 days ago
Switching from thiazide diuretic to ipragliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, leads to improvements in metabolic parameters and body mass composition without affecting blood pressure in type 2 diabetes (T2D) patients, a recent study has found.

Shockwave therapy effective for erectile dysfunction

17 Mar 2018
Sexual health in men – supplements vs medication

The total number of shockwave therapy significantly affects treatment efficacy, according to a recent study, which has shown improved sexual function in erectile dysfunction patients undergoing 12 vs 6 shockwave therapy sessions.

The researchers randomized 42 adults with vasculogenic erectile dysfunction to receive low-intensity shockwave therapy either once (group A; n=21) or twice (group B; n=21) a week for 6 consecutive weeks. Six additional sessions were offered for the second phase of the study, where group A received two sessions per week and group B received one session per week.

In the entire cohort the mean score in the erectile function domain of the International Index for Erectile Function (IIEF-EF) significantly increased after the 6-week treatment (15.8±3.7 to 19.9±3.8; p<0.001).

For group A, scores after 1 month, 3 months and 6 months were 19.5, 19.0 and 19.3 points, respectively, indicating significant improvements from the 16.2 score at baseline (p<0.001). The respective improvements in group B were greater (20.6, 20.6 and 20.5 points; p<0.001).

At 6 months, group B had significantly better outcomes in the Sexual Encounter Profile than group A. Compared to 47 percent in group A, 65 percent in group B affirmed that their erections lasted long enough for successful intercourse. The between-group difference reached significance (p=0.02).

Retreatment with the six additional sessions resulted in further significant improvements in IIEF-EF scores. Scores increased from 20.3±3.5 points at baseline to 22.1±4.3 points at the 6-month follow-up after the six additional sessions (p<0.001).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 4 days ago
Diabetic patients in a decompensated state and who develop type 2 myocardial infarction (MI) have an increased risk for mortality and major adverse cardiac events (MACE), according to a new study. In addition, these patients are potentially at risk for undiagnosed coronary artery disease.
6 days ago
Chocolate consumption is not associated with risk of coronary heart disease (CHD), stroke or both combined in postmenopausal women free of pre-existing major chronic disease, a study suggests.
Pearl Toh, 13 Jul 2018
More intensive lowering of LDL-C levels was associated with a progressively greater survival benefit than less intensive approach, when the baseline LDL-C levels were ≥100 mg/dL, reveals a meta-analysis of 34 randomized trials.
6 days ago
Switching from thiazide diuretic to ipragliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, leads to improvements in metabolic parameters and body mass composition without affecting blood pressure in type 2 diabetes (T2D) patients, a recent study has found.